









Markets
/
Stocks
/
nasdaq-vrax
/

Virax Biolabs Group Ltd

VRAX

0.370USD

+0.020+5.69%

Close 12/24, 13:00（ET）Quotes delayed by 15 min

2.42MMarket Cap

LossP/E TTM



Virax Biolabs Group Ltd

0.370

+0.020+5.69%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Virax Biolabs Group Ltd to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025H1

FY2024H2

FY2024H1

FY2023H2

FY2023H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

46.62%-1.92M

-48.11%-2.79M

-56.50%-3.59M

---1.88M

---2.30M

Net income from continuing operations

5.41%-2.76M

4.47%-3.82M

-100.46%-2.91M

---4.00M

---1.45M

Operating gains losses

792.78%158.19K

--475.74K

--17.72K

----

Other non-cash items

177.06%52.45K

159.39%174.77K

---68.06K

---294.27K

----

Change in working capital

178.71%568.36K

-158.75%-534.21K

33.85%-722.11K

--909.36K

---1.09M

-Change in receivables

204.54%191.69K

---34.48K

---183.36K

----

-Change in inventory

-164.70%-64.87K

---35.88K

-216.98%-24.51K

--0.00

--20.95K

-Change in prepaid expenses

77.76%-83.15K

-67.76%142.64K

47.91%-373.95K

--442.39K

---717.87K

-Change in payables and accrued expense

713.01%301.97K

-223.34%-522.99K

87.37%-49.26K

--424.02K

---390.08K

-Change in other current assets

----

--4.69K

---4.69K

-Change in other current liabilities

220.72%222.73K

-73.98%9.95K

---184.50K

--38.25K

----

Cash from non-recurring investing activities

Cash from operating activities

46.62%-1.92M

-48.11%-2.79M

-56.50%-3.59M

---1.88M

---2.30M

Investing cash flow

Net cash from continuing investing activities

-64.98%248.00K

155.75%456.27K

--708.18K

--178.40K

----

Capital expenditures

-64.98%248.00K

166.59%475.61K

--708.18K

--178.40K

----

Net cash flow from disposal of fixed assets

-49.65%248.00K

--459.92K

--492.58K

----

Net cash flow from intangible asset transactions

-100.00%0.00

-102.05%-3.65K

--215.60K

--178.40K

----

Cash from non-current investing activities

Net cash flow from investing activities

64.98%-248.00K

-155.75%-456.27K

---708.18K

---178.40K

----

Financing cash flow

Cash flow from continuous financing activities

10099.64%5.86M

-74.77%1.73M

-99.16%57.49K

--6.84M

Net cash flow from debt Issuance/repayment

-418.04%-51.55K

75.38%-60.02K

-102.55%-9.95K

---243.75K

--390.00K

Net cash flow from common stock issuance/repurchase

2191432.48%5.13M

-100.00%0.00

-100.00%234.00

--7.10M

--6.56M

Proceeds from issuance of warrants

--786.74K

--1.87M

--0.00

----

Net cash flow from other financing activities

-100.00%0.00

-855.63%-85.50K

165.44%67.20K

---8.95K

---102.70K

Net cash from non-recurrent financing activities

Net cash from financing activities

10099.64%5.86M

-74.77%1.73M

-99.16%57.49K

--6.84M

Net cash flow

Beginning cash balance

-61.62%3.59M

11.77%5.11M

42888.32%9.35M

--4.57M

--21.76K

Current period cash flow changes

187.09%3.70M

-131.75%-1.52M

-193.32%-4.24M

--4.78M

--4.55M

Ending cash balance

42.64%7.29M

-61.62%3.59M

11.77%5.11M

--9.35M

--4.57M

Free cash flow

49.64%-2.17M

-58.36%-3.26M

---4.30M

---2.06M

----

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

